Sec Form 13D Filing - BAUM MARK L filing for Harrow Health, Inc. (HROW) - 2025-04-07

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
The amount set forth in line 11 consists of (a) 2,599,462 shares of Common Stock held by Mr. Baum and (b) options to purchase 1,457,500 shares of Common Stock held by Mr. Baum and exercisable within 60 days after the date of the filing of this Amendment No. 3.The percentage set forth in line 13 was calculated based on 37,951,088 shares of Common Stock, of the Issuer which represents the sum of: (a) 36,493,588 shares of Common Stock outstanding as of April 7, 2025, and (b) 1,457,500 shares of Common Stock issuable upon the exercise of options to purchase shares of Common Stock held by Mr. Baum and exercisable within 60 days after the date of the filing of this Amendment No. 3.


SCHEDULE 13D

 
Mark L. Baum
 
Signature:Mark L. Baum
Name/Title:Mark L. Baum
Date:04/07/2025
primary_doc.xml